Trials / Unknown
UnknownNCT04403750
Combined Laser-surgical Technology of RRD Treatment
Combined Laser-surgical Technology of Rhegmatogenous Retinal Detachment Treatment
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- The S.N. Fyodorov Eye Microsurgery State Institution · Other Government
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Purpose: to assess the efficacy and safety of combined laser-surgical technology of RRD treatment
Detailed description
The study takes place in the S.N. Fyodorov "Eye Microsurgery" Federal State Institution located in Moscow, Russian Federation. The study will include 50 patients with rhegmatogenous retinal detachment due to a horseshoe-tear. In addition to the standard ophthalmological examination, all patients will undergo wide-field optical coherence tomography to determine the extension and localization of the vitreoretinal traction zone. The obtained data will be used to planning the 1st step of laser-surgical treatment. All patients will undergo a combined laser-surgical technology, which includes 3 steps: 1) Nd-YAG laser excision of the vitreoretinal traction zone 2) pneumatic retinopexy (10% C3F8) 3) barrier laser photocoagulation around retinal break after retinal attachment. The patients are going to be followed up for at least 1 year, the main outcome measures are postoperative primary and final anatomic outcome, BCVA and complications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Combined laser-surgical technology of RRD treatment | 1. Nd-YAG laser excision of the vitreoretinal traction zone 2. Pneumatic retinopexy (10% C3F8) 3. barrier laser photocoagulation around retinal break after retinal attachment (2-3 days after pneumatic retinopexy) |
Timeline
- Start date
- 2018-09-15
- Primary completion
- 2020-06-25
- Completion
- 2021-06-01
- First posted
- 2020-05-27
- Last updated
- 2020-05-29
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT04403750. Inclusion in this directory is not an endorsement.